Hoover, AL, United States of America

Xini Zhang


Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 115(Granted Patents)


Location History:

  • Wilmington, DE (US) (1997)
  • Hoover, AL (US) (1998 - 1999)
  • Jericho, NJ (US) (1999)
  • Jericho, NY (US) (2002)

Company Filing History:


Years Active: 1997-2002

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xini Zhang

Introduction

Xini Zhang is a notable inventor based in Hoover, Alabama, with a significant portfolio of six patents. His work primarily focuses on advancements in medical research, particularly in the fields of amyloidosis and anthracycline derivatives. Zhang's contributions have the potential to impact the treatment of neurodegenerative diseases and diabetes.

Latest Patents

One of Zhang's latest patents is titled "Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis." This invention addresses the non-enzymatic glycosylation of amyloidogenic proteins, which can enhance amyloidosis. The patent outlines methods for preventing and treating amyloidosis associated with diseases such as Alzheimer's and Type II diabetes. Another significant patent involves "Processes for preparing 13-deoxy anthracycline derivatives," which details a method for synthesizing these important compounds.

Career Highlights

Throughout his career, Xini Zhang has worked with esteemed organizations, including the Picower Institute for Medical Research and Gem Pharmaceuticals, LLC. His experience in these institutions has allowed him to develop innovative solutions to complex medical challenges.

Collaborations

Zhang has collaborated with notable professionals in his field, including Peter C. Ulrich and Anthony Cerami. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Xini Zhang's innovative work in the field of medical research showcases his dedication to addressing critical health issues. His patents reflect a commitment to improving treatment options for diseases that significantly impact quality of life.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…